JPS58162512A - 若禿及び円型脱毛の発毛剤 - Google Patents
若禿及び円型脱毛の発毛剤Info
- Publication number
- JPS58162512A JPS58162512A JP4510382A JP4510382A JPS58162512A JP S58162512 A JPS58162512 A JP S58162512A JP 4510382 A JP4510382 A JP 4510382A JP 4510382 A JP4510382 A JP 4510382A JP S58162512 A JPS58162512 A JP S58162512A
- Authority
- JP
- Japan
- Prior art keywords
- hair
- hair loss
- head
- observed
- loss
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000004384 Alopecia Diseases 0.000 title claims description 128
- 230000003676 hair loss Effects 0.000 title claims description 119
- 230000002028 premature Effects 0.000 title claims description 20
- 210000004209 hair Anatomy 0.000 title abstract description 85
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 24
- 235000019441 ethanol Nutrition 0.000 claims abstract description 12
- 208000024963 hair loss Diseases 0.000 claims description 90
- 230000003779 hair growth Effects 0.000 claims description 21
- 210000001732 sebaceous gland Anatomy 0.000 abstract description 21
- 239000011159 matrix material Substances 0.000 abstract description 13
- 239000003795 chemical substances by application Substances 0.000 abstract description 12
- 229940088597 hormone Drugs 0.000 abstract description 10
- 239000005556 hormone Substances 0.000 abstract description 10
- FCKLFGKATYPJPG-SSTBVEFVSA-N Oxendolone Chemical compound C1CC2=CC(=O)CC[C@@H]2[C@@H]2[C@@H]1[C@@H]1C[C@H](CC)[C@H](O)[C@@]1(C)CC2 FCKLFGKATYPJPG-SSTBVEFVSA-N 0.000 abstract description 5
- 239000000126 substance Substances 0.000 abstract description 5
- 230000009471 action Effects 0.000 abstract description 4
- 229950006827 oxendolone Drugs 0.000 abstract description 4
- 108090000790 Enzymes Proteins 0.000 abstract description 3
- 102000004190 Enzymes Human genes 0.000 abstract description 3
- 239000013078 crystal Substances 0.000 abstract description 3
- 238000002844 melting Methods 0.000 abstract description 3
- 230000008018 melting Effects 0.000 abstract description 3
- 239000000843 powder Substances 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract 4
- 230000009965 odorless effect Effects 0.000 abstract 1
- 210000003128 head Anatomy 0.000 description 54
- 230000000694 effects Effects 0.000 description 34
- 208000004631 alopecia areata Diseases 0.000 description 24
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 23
- 210000001061 forehead Anatomy 0.000 description 20
- 231100000957 no side effect Toxicity 0.000 description 18
- 238000011282 treatment Methods 0.000 description 18
- 239000003814 drug Substances 0.000 description 16
- 239000000243 solution Substances 0.000 description 14
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 13
- 208000003251 Pruritus Diseases 0.000 description 13
- 229940079593 drug Drugs 0.000 description 13
- 230000007803 itching Effects 0.000 description 12
- 210000004761 scalp Anatomy 0.000 description 11
- 229960003604 testosterone Drugs 0.000 description 11
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 9
- 102000005962 receptors Human genes 0.000 description 9
- 108020003175 receptors Proteins 0.000 description 9
- 230000006872 improvement Effects 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 231100000360 alopecia Toxicity 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 210000002374 sebum Anatomy 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000005856 abnormality Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 230000003340 mental effect Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 230000003211 malignant effect Effects 0.000 description 4
- 230000010534 mechanism of action Effects 0.000 description 4
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 4
- 230000035807 sensation Effects 0.000 description 4
- 150000003431 steroids Chemical class 0.000 description 4
- 230000009885 systemic effect Effects 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- 208000001840 Dandruff Diseases 0.000 description 3
- 208000007684 Occupational Stress Diseases 0.000 description 3
- 108090000854 Oxidoreductases Proteins 0.000 description 3
- 102000004316 Oxidoreductases Human genes 0.000 description 3
- 230000007059 acute toxicity Effects 0.000 description 3
- 231100000403 acute toxicity Toxicity 0.000 description 3
- 210000004100 adrenal gland Anatomy 0.000 description 3
- 206010068168 androgenetic alopecia Diseases 0.000 description 3
- 201000002996 androgenic alopecia Diseases 0.000 description 3
- 229960003473 androstanolone Drugs 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 229940126701 oral medication Drugs 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 150000000592 5α-dihydrotestosterones Chemical class 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 102000007399 Nuclear hormone receptor Human genes 0.000 description 2
- 206010039792 Seborrhoea Diseases 0.000 description 2
- 235000019013 Viburnum opulus Nutrition 0.000 description 2
- 244000071378 Viburnum opulus Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 102000001307 androgen receptors Human genes 0.000 description 2
- 108010080146 androgen receptors Proteins 0.000 description 2
- 239000000051 antiandrogen Substances 0.000 description 2
- 239000007900 aqueous suspension Substances 0.000 description 2
- 230000008952 bacterial invasion Effects 0.000 description 2
- 238000009534 blood test Methods 0.000 description 2
- 230000009918 complex formation Effects 0.000 description 2
- 108091007930 cytoplasmic receptors Proteins 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000004709 eyebrow Anatomy 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 230000003660 hair regeneration Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000000366 juvenile effect Effects 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 230000037312 oily skin Effects 0.000 description 2
- 230000005813 organ abnormality Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- YQACAXHKQZCEOI-UDCWSGSHSA-N (8s,9s,10r,13s,14s,17s)-10,13-dimethyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-17-carboxylic acid Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)C(O)=O)[C@@H]4[C@@H]3CCC2=C1 YQACAXHKQZCEOI-UDCWSGSHSA-N 0.000 description 1
- SMNNDVUKAKPGDD-UHFFFAOYSA-M 2-butylbenzoate Chemical compound CCCCC1=CC=CC=C1C([O-])=O SMNNDVUKAKPGDD-UHFFFAOYSA-M 0.000 description 1
- 108010029908 3-oxo-5-alpha-steroid 4-dehydrogenase Proteins 0.000 description 1
- 102000001779 3-oxo-5-alpha-steroid 4-dehydrogenase Human genes 0.000 description 1
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 1
- 235000017491 Bambusa tulda Nutrition 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 241001492658 Cyanea koolauensis Species 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 244000082204 Phyllostachys viridis Species 0.000 description 1
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000011425 bamboo Substances 0.000 description 1
- 238000007630 basic procedure Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000004700 cellular uptake Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- ZOSVFAIIFHTUEG-UHFFFAOYSA-L dipotassium;dihydroxide Chemical compound [OH-].[OH-].[K+].[K+] ZOSVFAIIFHTUEG-UHFFFAOYSA-L 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 210000004013 groin Anatomy 0.000 description 1
- 230000003659 hair regrowth Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000011278 mitosis Effects 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000057 systemic toxicity Toxicity 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000003813 thin hair Effects 0.000 description 1
- 229940126702 topical medication Drugs 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4510382A JPS58162512A (ja) | 1982-03-20 | 1982-03-20 | 若禿及び円型脱毛の発毛剤 |
| GR70817A GR77885B (enrdf_load_stackoverflow) | 1982-03-20 | 1983-03-16 | |
| GB08307346A GB2122081B (en) | 1982-03-20 | 1983-03-17 | Hair growth promotor containing oxendolone |
| NL8300972A NL8300972A (nl) | 1982-03-20 | 1983-03-17 | Haargroeimiddel. |
| FR8304501A FR2523440A1 (fr) | 1982-03-20 | 1983-03-18 | Composition cosmetique pour le traitement des cheveux et du cuir chevelu contenant de l'oxendolone |
| DE19833309813 DE3309813A1 (de) | 1982-03-20 | 1983-03-18 | Haarwuchsmittel |
| BE0/210358A BE896213A (fr) | 1982-03-20 | 1983-03-18 | Produit favorisant la croissance des cheveux et son utilisation |
| AU12573/83A AU559145B2 (en) | 1982-03-20 | 1983-03-18 | Hair growth promotion using oxendolone |
| CH1498/83A CH657774A5 (de) | 1982-03-20 | 1983-03-18 | Haarwuchsmittel. |
| CA000424076A CA1222460A (en) | 1982-03-20 | 1983-03-21 | Hair grower |
| IT67316/83A IT1162843B (it) | 1982-03-20 | 1983-03-21 | Utilizzazione dell'oxendolone e relativo preparato per favorire la crescita dei capelli |
| SG24/89A SG2489G (en) | 1982-03-20 | 1989-01-11 | Hair grower |
| HK577/89A HK57789A (en) | 1982-03-20 | 1989-07-20 | Hair grower |
| US08/132,487 USH1551H (en) | 1982-03-20 | 1993-10-06 | Topical composition and method for reducing hair loss from human scalp |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4510382A JPS58162512A (ja) | 1982-03-20 | 1982-03-20 | 若禿及び円型脱毛の発毛剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS58162512A true JPS58162512A (ja) | 1983-09-27 |
| JPH0112725B2 JPH0112725B2 (enrdf_load_stackoverflow) | 1989-03-02 |
Family
ID=12709947
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4510382A Granted JPS58162512A (ja) | 1982-03-20 | 1982-03-20 | 若禿及び円型脱毛の発毛剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS58162512A (enrdf_load_stackoverflow) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5931708A (ja) * | 1982-08-16 | 1984-02-20 | Chieko Takagi | 発毛、養毛促進剤 |
| JPS6064910A (ja) * | 1983-09-20 | 1985-04-13 | Shiseido Co Ltd | 養毛料 |
| JPS6127914A (ja) * | 1984-07-17 | 1986-02-07 | Shiseido Co Ltd | 化粧料 |
| JPS6256417A (ja) * | 1985-09-05 | 1987-03-12 | Shiseido Co Ltd | 頭髪化粧料 |
| JPS62201896A (ja) * | 1986-02-28 | 1987-09-05 | Shiseido Co Ltd | 多毛症治療剤 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3856829A (en) * | 1970-01-07 | 1974-12-24 | Takeda Chemical Industries Ltd | 16{62 -hydrocarbon substituted estrane compounds |
| JPS53119862A (en) * | 1977-03-28 | 1978-10-19 | Gist Brocades Nv | Novel steroid |
| JPS55120506A (en) * | 1979-03-12 | 1980-09-17 | Tamu Yurugen | Hair and skin treating cosmetic |
-
1982
- 1982-03-20 JP JP4510382A patent/JPS58162512A/ja active Granted
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3856829A (en) * | 1970-01-07 | 1974-12-24 | Takeda Chemical Industries Ltd | 16{62 -hydrocarbon substituted estrane compounds |
| JPS53119862A (en) * | 1977-03-28 | 1978-10-19 | Gist Brocades Nv | Novel steroid |
| JPS55120506A (en) * | 1979-03-12 | 1980-09-17 | Tamu Yurugen | Hair and skin treating cosmetic |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5931708A (ja) * | 1982-08-16 | 1984-02-20 | Chieko Takagi | 発毛、養毛促進剤 |
| JPS6064910A (ja) * | 1983-09-20 | 1985-04-13 | Shiseido Co Ltd | 養毛料 |
| JPS6127914A (ja) * | 1984-07-17 | 1986-02-07 | Shiseido Co Ltd | 化粧料 |
| JPS6256417A (ja) * | 1985-09-05 | 1987-03-12 | Shiseido Co Ltd | 頭髪化粧料 |
| JPS62201896A (ja) * | 1986-02-28 | 1987-09-05 | Shiseido Co Ltd | 多毛症治療剤 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0112725B2 (enrdf_load_stackoverflow) | 1989-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5962505A (en) | Method for treating hot flashes in humans | |
| DE69415535T2 (de) | Verfahren zur regulierung der sexuellen reaktion beim menschen | |
| KR102586868B1 (ko) | 연성 항콜린성 유사체를 위한 제제 | |
| US10632181B2 (en) | Composition, containing RGD motif-containing peptide or fragment thereof, for treating burns and glaucoma, alleviating skin wrinkles, and promoting hair growth | |
| EP2431031B1 (en) | Composition for preventing hair loss or for stimulating hair growth | |
| JPH11502513A (ja) | 糖尿病性ニューロパシーの処置方法 | |
| JPS62502118A (ja) | メラトニン組成物とその使用 | |
| US6465514B1 (en) | Methods and compositions for the promotion of hair growth | |
| JPH02502818A (ja) | 遺伝性脱毛症を治療するためのミノキシジルおよび抗炎症剤の組合わせ | |
| BR112021004550A2 (pt) | usos de inibidores de inibidor de ativador de plasminogênio 1 (pai-1) | |
| BRPI1007812B1 (pt) | Lipoatrofia cosmetic medicinal | |
| BR112021004542A2 (pt) | inibidores do inibidor de ativador de plasminogênio 1 (pai-1) e usos para os mesmos | |
| KR100998992B1 (ko) | 두피 및 모발 상태 개선용 조성물 | |
| JPH04500824A (ja) | 光老化の作用を回復させるための皮膚の治療方法 | |
| AU762126B2 (en) | Method for treating hot flashes in humans | |
| JPS58162512A (ja) | 若禿及び円型脱毛の発毛剤 | |
| US6187815B1 (en) | Methods and compositions for the promotion of hair growth | |
| EP2253304B1 (en) | Nifedipine-based compositions for anti-wrinkle treatments | |
| USH1551H (en) | Topical composition and method for reducing hair loss from human scalp | |
| RU2321397C2 (ru) | Композиция для лечения витилиго | |
| JPS6011884B2 (ja) | 毛髪及び皮膚手入用化粧料 | |
| KR102811862B1 (ko) | 트로폴론을 포함하는 광반응성 피부 탄력 증진 및/또는 주름 개선용 조성물 | |
| JP3327405B2 (ja) | テストステロン ５αーレダクターゼ阻害剤 | |
| CA1238281A (en) | Hair treating agent and method of treating hair | |
| JP2007016025A (ja) | 皮膚の局部組成物及び方法 |